Can Fite Biopharma Ltd Stock Price, News & Analysis (NYSEAMERICAN:CANF)

$1.44 -0.04 (-2.70 %)
(As of 11/18/2017 02:41 PM ET)
Previous Close$1.44
Today's Range$1.38 - $1.46
52-Week Range$1.31 - $2.67
Volume19,936 shs
Average Volume30,771 shs
Market Capitalization$24.54 million
P/E RatioN/A
Dividend YieldN/A
Beta1.43

About Can Fite Biopharma Ltd (NYSEAMERICAN:CANF)

Can Fite Biopharma Ltd logoCan Fite Biofarma Ltd is an Israel-based biopharmaceutical company. The Company develops new treatments for autoimmune diseases and cancer. The Company's drugs are CF101 for Psoriasis treatment, RA treatment, for the treatment of Keratoconjunctictivitis Sicca, for the treatment of Glaucoma, among others; and CF102 for the treatment of liver diseases. The Company has a research infrastructure including research laboratories and animal house facilities run by the development team. Can Fite Biofarma Ltd signed distribution contracts with a Kwang Dong Pharmaceutical Co. allowing distribution of CF101 for arthritis in Korea and Seikagaku Corp. for distribution in Japan. The Company operates three subsidiaries, Ultratrend Ltd, EyeFite Ltd and OphathaliX Inc.


Industry, Sector and Symbol:
  • Industry: Biotechnology & Medical Research
  • Sub-Industry: N/A
  • Sector: Biotechnology & Medical Research - NEC
  • Symbol: NYSEAMERICAN:CANF
  • CUSIP: N/A
  • Web: www.canfite.co.il
Debt:
  • Current Ratio: 7.29%
Profitability:
  • Trailing EPS: $0.25
  • Net Margins: -2,453.03%
  • Return on Equity: -57.94%
  • Return on Assets: -32.52%
Misc:
  • Employees: 7
  • Outstanding Shares: 16,580,000
 

Frequently Asked Questions for Can Fite Biopharma Ltd (NYSEAMERICAN:CANF)

What is Can Fite Biopharma Ltd's stock symbol?

Can Fite Biopharma Ltd trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "CANF."

How were Can Fite Biopharma Ltd's earnings last quarter?

Can Fite Biopharma Ltd (NYSEAMERICAN:CANF) announced its quarterly earnings results on Tuesday, May, 31st. The biotechnology company reported ($0.12) earnings per share (EPS) for the quarter, missing the Zacks' consensus estimate of ($0.09) by $0.03. Can Fite Biopharma Ltd had a negative return on equity of 57.94% and a negative net margin of 2,453.03%. View Can Fite Biopharma Ltd's Earnings History.

When will Can Fite Biopharma Ltd make its next earnings announcement?

Can Fite Biopharma Ltd is scheduled to release their next quarterly earnings announcement on Friday, November, 24th 2017. View Earnings Estimates for Can Fite Biopharma Ltd.

Where is Can Fite Biopharma Ltd's stock going? Where will Can Fite Biopharma Ltd's stock price be in 2017?

2 equities research analysts have issued twelve-month target prices for Can Fite Biopharma Ltd's shares. Their forecasts range from $6.00 to $7.00. On average, they anticipate Can Fite Biopharma Ltd's share price to reach $6.50 in the next twelve months. View Analyst Ratings for Can Fite Biopharma Ltd.

Who are some of Can Fite Biopharma Ltd's key competitors?

Who are Can Fite Biopharma Ltd's key executives?

Can Fite Biopharma Ltd's management team includes the folowing people:

  • Ilan Cohen, Chairman of the Board (Age 61)
  • Pnina Fishman Ph.D., Chief Executive Officer, Director (Age 67)
  • Motti Farbstein, Chief Financial Officer, Chief Operating Officer (Age 51)
  • Guy Regev, Director (Age 47)
  • Abraham Sartani M.D., Director (Age 68)
  • Israel Shamay, External Director (Age 51)

How do I buy Can Fite Biopharma Ltd stock?

Shares of Can Fite Biopharma Ltd can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Can Fite Biopharma Ltd's stock price today?

One share of Can Fite Biopharma Ltd stock can currently be purchased for approximately $1.44.

How big of a company is Can Fite Biopharma Ltd?

Can Fite Biopharma Ltd has a market capitalization of $24.54 million. Can Fite Biopharma Ltd employs 7 workers across the globe.

How can I contact Can Fite Biopharma Ltd?

Can Fite Biopharma Ltd's mailing address is 10 Bareket Street, Kiryat Matalon P.O. Box 7537, PETAH TIKVA, 49170, Israel. The biotechnology company can be reached via phone at +972-3-9241114.


MarketBeat Community Rating for Can Fite Biopharma Ltd (NYSEAMERICAN CANF)

Community Ranking:  3.1 out of 5 (star star star)
Outperform Votes:  72 (Vote Outperform)
Underperform Votes:  46 (Vote Underperform)
Total Votes:  118
MarketBeat's community ratings are surveys of what our community members think about Can Fite Biopharma Ltd and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Analysts' Consensus Rating for Can Fite Biopharma Ltd (NYSEAMERICAN:CANF)

  (How are Consensus Ratings Calculated?)
Ratings Breakdown: 0 Sell Ratings, 0 Hold Ratings, 2 Buy Ratings, 0 Strong Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $6.50

Consensus Price Target History for Can Fite Biopharma Ltd (NYSEAMERICAN:CANF)

Price Target History for Can Fite Biopharma Ltd (NYSEAMERICAN:CANF)

Analysts' Ratings History for Can Fite Biopharma Ltd (NYSEAMERICAN:CANF)

Show:
DateFirmActionRatingPrice TargetDetails
10/31/2017HC WainwrightReiterated RatingBuyView Rating Details
10/30/2017Maxim GroupSet Price TargetBuy$7.00View Rating Details
10/18/2016Roth CapitalReiterated RatingBuyView Rating Details
8/29/2016Rodman & RenshawInitiated CoverageBuy$6.00View Rating Details
(Data available from 11/19/2015 forward)

Earnings

Earnings History and Estimates Chart for Can Fite Biopharma Ltd (NYSEAMERICAN:CANF)

Earnings by Quarter for Can Fite Biopharma Ltd (NYSEAMERICAN:CANF)

Earnings History by Quarter for Can Fite Biopharma Ltd (NYSEAMERICAN CANF)

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/24/2017        
5/31/2016Q116($0.09)($0.12)ViewN/AView Earnings Details
5/29/2015Q115($0.12)($0.04)ViewN/AView Earnings Details
4/8/2015($0.15)($0.20)ViewN/AView Earnings Details
12/2/2014($0.24)($0.10)ViewN/AView Earnings Details
9/3/2014($0.36)($0.20)ViewN/AView Earnings Details
5/30/2014($0.23)($0.22)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Can Fite Biopharma Ltd (NYSEAMERICAN:CANF)

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Can Fite Biopharma Ltd (NYSEAMERICAN:CANF)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Can Fite Biopharma Ltd (NYSEAMERICAN CANF)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Latest Headlines for Can Fite Biopharma Ltd (NYSEAMERICAN CANF)

Source:

Social Media

Social activity is not available for this stock.

Financials

Financials are not available for this stock.

Chart

Can Fite Biopharma Ltd (NYSEAMERICAN CANF) Chart for Sunday, November, 19, 2017
Loading chart…

This page was last updated on 11/19/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.